Abstract
Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and is the leading cause of end-stage renal disease (ESRD). Genetic, metabolic, systemic, and renal hemodynamic factors are involved in the pathogenesis of DN. Advanced glycation end products (AGEs), hypertension, oxidative stress, inflammation, and genetic susceptibility are risk factors for susceptibility to DN and its development. Management approaches of DN are based on the inhibitors of some components of the renin angiotensin aldosterone system (RAAS), AGEs, and protein kinase C (PKC) and combined antioxidants therapy with anti-inflammatory agents. The present review looks at some mechanisms involved in DN and its progression and also management approaches according to the inhibition of the risk factors of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Kermanshah University of Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
